AstraZeneca PLC, Cubist Pharmaceuticals, Inc., Astellas Pharma Inc. Said to Make Bids for Optimer Pharmaceuticals, Inc.

Published: May 15, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

AstraZeneca Plc (AZN) and Cubist Pharmaceuticals Inc. (CBST) are among the suitors that made first-round bids for Optimer Pharmaceuticals Inc. (OPTR), the antibiotics maker weighing a sale, said people familiar with the matter. The stock surged 14 percent. The maker of the Dificid drug used to treat intestinal infections also attracted an offer from Japan’s Astellas Pharma Inc. (4503) and others, said the people, who asked not to be named because the process is private. Optimer’s managers will make presentations to bidders later in the month, one person said. Optimer’s drug is sold for use in hospitals. All the bidders are health-care companies that could also sell the treatment to medical centers, one of the people said.

Help employers find you! Check out all the jobs and post your resume.

Back to news